CS logo
small CS logo
Szpital Specjalistyczny nr 1; Oddzial Okulistyki

Bytom, Poland
Hospital in Bytom
Stefana Żeromskiego 7, 41-902 Bytom

About Szpital Specjalistyczny nr 1; Oddzial Okulistyki


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Szpital Specjalistyczny nr 1; Oddzial Okulistyki


During the past decade, Szpital Specjalistyczny nr 1; Oddzial Okulistyki conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Szpital Specjalistyczny nr 1; Oddzial Okulistyki


According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" are "Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" in a lesser frequency.

Clinical Trials Intervention Types at Szpital Specjalistyczny nr 1; Oddzial Okulistyki


Most popular intervention types in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" are "Drug" (8 trials), "Other" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Lampalizumab" (2 trials) and "No intervention" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Szpital Specjalistyczny nr 1; Oddzial Okulistyki


The vast majority of trials in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" are 9 trials for "All" genders.

Clinical Trials Status at Szpital Specjalistyczny nr 1; Oddzial Okulistyki


Currently, there are NaN active trials in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Szpital Specjalistyczny nr 1; Oddzial Okulistyki, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Specjalistyczny nr 1; Oddzial Okulistyki, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".